Key result
The M8R tropomyosin mutation disrupts the four-helix bundle at the head-to-tail junction, leading to weaker tropomyosin-actin binding, decreased calcium sensitivity, and altered cooperativity.
The M8R tropomyosin mutation disrupts tropomyosin-thin filament interactions and calcium sensitivity, providing a molecular basis for the pathogenesis of dilated cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
No immediate clinical implications for DCM; leaves open human validation of M8R effects on contractility.
Racca et al. (2020) studied Dilated cardiomyopathy (DCM). M8R tropomyosin mutation vs. Wild-type tropomyosin was evaluated on Actin binding, filament regulation, calcium sensitivity, and thin filament cooperativity. The M8R tropomyosin mutation disrupts the four-helix bundle at the head-to-tail junction, leading to weaker tropomyosin-actin binding, decreased calcium sensitivity, and altered cooperativity.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: